Could a Bacteria-Based injection prevent implant complications?
NCT ID NCT07460297
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an inactivated Pseudomonas aeruginosa injection, combined with an iodine wash, can reduce complications like infection and capsular contracture in women undergoing immediate breast reconstruction with implants after cancer surgery. The trial involves 100 participants and measures how quickly drainage tubes can be removed and how well the implant capsule forms. The goal is to improve recovery and patient satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Inactivated Pseudomonas aeruginosa injection (PAP) and povidone-iodine
What this could lead to
If it works, this could reduce infection and capsular contracture after breast reconstruction, improving recovery and satisfaction.
What could go wrong
This is an early-stage trial with only 100 participants, so results may not apply widely. The treatment involves a bacterial injection, which could cause unexpected inflammation or side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Liaoning Cancer Hospital and Institute
Shenyang, Liaoning, 110000, China